CT invests $850K in New Haven biotech

Connecticut has pumped $850,000 into a New Haven biotech developing a test kit for leaking brain and spinal fluid.

Connecticut Innovations Inc.'s stake was part of a investment round of more than $1 million in Affinimark Technologies Inc. LauncCapital also was a participant.

Affinimark's Cerebrostrip kits are is used to detect leaking fluid caused by injury to the brain and/or spinal cord due to surgery or accident.

CI obtained a seat on Affinimark's board.